Healthpeak Properties (NYSE:DOC) Issues Quarterly Earnings Results, Misses Estimates By $0.23 EPS

Healthpeak Properties (NYSE:DOC) released its earnings results on Thursday. The real estate investment trust reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.23), Zacks reports. Healthpeak Properties had a return on equity of 3.69% and a net margin of 11.93%. The business had revenue of $695.50 million for the quarter, compared to analysts’ expectations of $665.11 million. During the same quarter last year, the company posted $0.45 earnings per share. The business’s quarterly revenue was up 27.5% compared to the same quarter last year. Healthpeak Properties updated its FY 2024 guidance to 1.770-1.810 EPS.

Healthpeak Properties Stock Up 5.5 %

Shares of DOC traded up $1.14 during trading on Friday, reaching $21.90. The company’s stock had a trading volume of 8,948,525 shares, compared to its average volume of 3,874,896. Healthpeak Properties has a twelve month low of $15.24 and a twelve month high of $22.38. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.92. The company has a market cap of $15.41 billion, a price-to-earnings ratio of 62.57, a P/E/G ratio of 2.73 and a beta of 1.11. The company has a fifty day moving average of $19.81 and a two-hundred day moving average of $17.23.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 16th. Shareholders of record on Monday, August 5th will be paid a dividend of $0.30 per share. The ex-dividend date is Monday, August 5th. This represents a $1.20 dividend on an annualized basis and a yield of 5.48%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 342.87%.

Analyst Ratings Changes

Several brokerages have recently weighed in on DOC. StockNews.com upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Tuesday, July 23rd. JPMorgan Chase & Co. upped their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “neutral” rating in a report on Thursday, May 16th. Mizuho reiterated a “buy” rating and issued a $22.00 target price on shares of Healthpeak Properties in a report on Monday, April 22nd. Scotiabank upped their price target on Healthpeak Properties from $22.00 to $23.00 and gave the stock a “sector outperform” rating in a research note on Thursday, May 16th. Finally, Wedbush upgraded Healthpeak Properties from a “neutral” rating to an “outperform” rating in a report on Friday, May 3rd. Six research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $19.90.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.